ENVERIC BIOSCIENCES, INC. Retained Earnings
ENVERIC BIOSCIENCES, INC. (ENVB) had Retained Earnings of -$119.51 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-14
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$119.51M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$116.48M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$114.85M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$112.65M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$119.51M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | -$116.48M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | -$114.85M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | -$112.65M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | -$110.78M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$108.26M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | -$106.07M 10-K · filed 2026-03-27 | |
| 2024-09-30 | -$102.92M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | -$100.84M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | -$98.96M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | -$96.50M 10-K · filed 2025-03-28 | |
| 2023-09-30 | -$93.06M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | -$90.24M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | -$83.89M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | -$79.21M 10-K · filed 2024-03-26 | |
| 2022-09-30 | -$70.53M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | -$68.05M 10-Q · filed 2022-08-12 | |
| 2022-03-31 | -$65.26M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | -$60.74M 10-K/A · filed 2023-06-09 | |
| 2021-09-30 | -$18.63M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | -$15.92M 10-Q · filed 2021-08-13 | |
| 2021-03-31 | -$15.01M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | -$11.76M 10-K · filed 2022-03-31 | |
| 2020-09-30 | -$45.16M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | -$44.09M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | -$42.40M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | -$4.89M 10-K · filed 2021-04-01 | -$40.51M 10-K · filed 2020-03-25 |
| 2019-09-30 | -$37.81M 10-K/A · filed 2020-08-12 | -$37.87M 10-Q · filed 2019-11-08 |
| 2019-06-30 | -$37.87M 10-K/A · filed 2020-08-12 | -$37.81M 10-Q · filed 2019-08-14 |
| 2019-03-31 | -$36.44M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | -$34.48M 10-K/A · filed 2020-08-12 | |
| 2018-09-30 | -$14.61M 10-Q · filed 2018-11-14 | |
| 2018-06-30 | -$18.49M 10-Q · filed 2018-08-14 | |
| 2018-03-31 | -$17.13M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | -$15.00M 10-K · filed 2019-03-26 | |
| 2017-09-30 | -$13.43M 10-Q · filed 2017-11-13 | |
| 2017-06-30 | -$8.83M 10-Q · filed 2017-08-14 | |
| 2017-03-31 | -$5.23M 10-Q/A · filed 2017-05-15 | |
| 2016-12-31 | -$3.83M 10-K · filed 2018-04-02 | |
| 2016-09-30 | -$5.14M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | -$3.42M 10-Q · filed 2016-08-12 | |
| 2016-03-31 | -$2.21M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$1.05M 10-K/A · filed 2017-04-04 | |
| 2015-09-30 | $699.46K 10-Q · filed 2015-11-23 | |
| 2015-06-30 | $948.83K 10-Q · filed 2015-08-18 | |
| 2015-03-31 | $837.86K 10-KT · filed 2016-03-15 | -$47.43M 10-Q · filed 2015-05-14 |
| 2014-12-31 | -$47.43M 10-Q · filed 2015-05-14 | |
| 2014-09-30 | -$47.42M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | -$47.41M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $414.56K 10-KT · filed 2016-03-15 | -$47.40M 10-Q/A · filed 2014-05-08 |
| 2013-12-31 | -$47.39M 10-K · filed 2015-03-31 | |
| 2013-09-30 | -$47.41M 10-Q · filed 2013-11-06 | |
| 2013-06-30 | -$47.40M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | -$47.40M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | -$47.39M 10-K · filed 2014-03-28 | |
| 2012-09-30 | -$47.38M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | -$47.38M 10-Q · filed 2012-08-01 | |
| 2012-03-31 | -$47.37M 10-Q/A · filed 2012-05-10 | |
| 2011-12-31 | -$47.37M 10-K · filed 2013-02-28 | |
| 2011-09-30 | -$47.35M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | -$47.35M 10-Q · filed 2011-08-02 | |
| 2010-12-31 | -$47.33M 10-K · filed 2012-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |